BE1003009A5 - Nouvelles compositions pharmaceutiques a base de cyclosporines. - Google Patents

Nouvelles compositions pharmaceutiques a base de cyclosporines. Download PDF

Info

Publication number
BE1003009A5
BE1003009A5 BE9000133A BE9000133A BE1003009A5 BE 1003009 A5 BE1003009 A5 BE 1003009A5 BE 9000133 A BE9000133 A BE 9000133A BE 9000133 A BE9000133 A BE 9000133A BE 1003009 A5 BE1003009 A5 BE 1003009A5
Authority
BE
Belgium
Prior art keywords
pharmaceutical compositions
cyclosporins
compositions based
novel pharmaceutical
cyclosporine
Prior art date
Application number
BE9000133A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898902898A external-priority patent/GB8902898D0/en
Priority claimed from GB898902901A external-priority patent/GB8902901D0/en
Priority claimed from GB898903147A external-priority patent/GB8903147D0/en
Priority claimed from GB898903663A external-priority patent/GB8903663D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Application granted granted Critical
Publication of BE1003009A5 publication Critical patent/BE1003009A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE9000133A 1989-02-09 1990-02-05 Nouvelles compositions pharmaceutiques a base de cyclosporines. BE1003009A5 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898902898A GB8902898D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898902901A GB8902901D0 (en) 1989-02-09 1989-02-09 Improvements in or relating to organic compounds
GB898903147A GB8903147D0 (en) 1989-02-13 1989-02-13 Improvements in or relating to organic compounds
GB898903663A GB8903663D0 (en) 1989-02-17 1989-02-17 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
BE1003009A5 true BE1003009A5 (fr) 1991-10-22

Family

ID=27450262

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9000133A BE1003009A5 (fr) 1989-02-09 1990-02-05 Nouvelles compositions pharmaceutiques a base de cyclosporines.

Country Status (25)

Country Link
JP (3) JP3484190B2 (nl)
KR (1) KR0170769B1 (nl)
AT (1) AT404552B (nl)
AU (1) AU630413B2 (nl)
BE (1) BE1003009A5 (nl)
CA (1) CA2009533C (nl)
CH (1) CH679277A5 (nl)
CY (1) CY1903A (nl)
DE (1) DE4003844B4 (nl)
DK (1) DK176209B1 (nl)
ES (1) ES2021942A6 (nl)
FI (1) FI97524C (nl)
FR (1) FR2642650B1 (nl)
GB (1) GB2230440B (nl)
HK (1) HK37296A (nl)
HU (1) HU213394B (nl)
IT (1) IT1240758B (nl)
LU (1) LU87675A1 (nl)
MY (1) MY107377A (nl)
NL (1) NL195028C (nl)
NO (1) NO301576B1 (nl)
NZ (1) NZ232401A (nl)
PH (1) PH30917A (nl)
PT (1) PT93079B (nl)
SE (1) SE511398C2 (nl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
HU208491B (en) * 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
MX9201782A (es) † 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5759566A (en) * 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
EP1142568A1 (en) 1992-09-25 2001-10-10 Novartis AG Pharmaceutical compositions containing cyclosporins
PT697881E (pt) † 1993-04-20 2002-10-31 Novartis Ag Novas composicoes farmaceuticas contendo ciclosporina para administracao oral
DE4412201A1 (de) * 1993-04-20 1994-11-10 Rentschler Arzneimittel Neue pharmazeutische Zubereitungen zur oralen Verabreichung enthaltend Cyclosporin
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
KR0146671B1 (ko) * 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
DK0789580T3 (da) 1994-11-03 2002-09-09 Novartis Ag Nye præparatformer for cyclosporin til oral administration med simpel sammensætning og høj biotilgængelighed, og fremgangsmåder til deres fremstilling
US5679566A (en) * 1995-01-20 1997-10-21 University Of Massachusetts Medical Center Yeast NMD2 gene
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5798333A (en) * 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
AU762247B2 (en) * 1997-01-30 2003-06-19 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
US6475519B1 (en) 1997-01-30 2002-11-05 Novartis Ag Oil-free pharmaceutical compositions containing cyclosporin A
IL131609A0 (en) * 1997-03-12 2001-01-28 Abbott Lab Hydrophilic binary systems for the administration of cyclosporine
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
KR20160033796A (ko) 2006-03-28 2016-03-28 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
US7495024B2 (en) 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
DE102008059201A1 (de) * 2008-11-27 2010-06-02 GÖPFERICH, Achim, Prof. Dr. In situ präzipitierende Arzneistofflösungen
KR102146704B1 (ko) 2018-04-13 2020-08-21 가천대학교 산학협력단 사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체
TW202330014A (zh) * 2021-10-13 2023-08-01 日商中外製藥股份有限公司 含有胜肽化合物及界面活性劑之組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015339A (en) * 1978-03-07 1979-09-12 Sandoz Ltd Compositions comprising mono-cyclic peptides
EP0230332A1 (en) * 1986-01-13 1987-07-29 N.V. Sanico A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
FR2620336A1 (fr) * 1987-09-15 1989-03-17 Sandoz Sa Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments
FR2636534A1 (fr) * 1988-09-16 1990-03-23 Sandoz Sa Compositions pharmaceutiques a base de cyclosporines

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280435A (ja) * 1985-04-04 1986-12-11 Kanji Takada サイクロスポリン類のリンパ指向性製剤
GB8602372D0 (en) * 1986-01-31 1986-03-05 Sandoz Ltd Organic compounds
CA1290249C (en) * 1986-04-09 1991-10-08 Cetus Corporation COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR
AU617295B2 (en) * 1986-11-13 1991-11-28 Sloan-Kettering Institute For Cancer Research Compositions and method for treatment of cancer using monoclonal antibody against gd3 ganglioside together with il-2
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
JP2536876B2 (ja) * 1987-07-31 1996-09-25 寛治 高田 シクロスポリンの溶解性粉末状製剤
DE3830494B4 (de) * 1987-09-15 2006-05-18 Novartis Ag Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
JP2792862B2 (ja) * 1988-07-30 1998-09-03 寛治 高田 経口腸溶製剤
JPH1038029A (ja) * 1996-07-26 1998-02-13 Ebara Corp 制振機能付き円板状構造物
JPH10280435A (ja) * 1997-04-03 1998-10-20 Sekisui Chem Co Ltd 地下室の構築方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015339A (en) * 1978-03-07 1979-09-12 Sandoz Ltd Compositions comprising mono-cyclic peptides
EP0230332A1 (en) * 1986-01-13 1987-07-29 N.V. Sanico A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof
FR2620336A1 (fr) * 1987-09-15 1989-03-17 Sandoz Sa Utilisation de monoesters solubles dans l'eau d'acides gras comme solubilisants de medicaments
FR2636534A1 (fr) * 1988-09-16 1990-03-23 Sandoz Sa Compositions pharmaceutiques a base de cyclosporines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 85, 1976, page 282, résumé no. 37149m, Columbus, Ohio, US; S. JANICKI et al.: "Effect of sucrose monoesters on the physical properties of tablets containing moprobamate", & FARM. POL. 1976, 32(2), 113-16 *
PHARMACEUTICAL RESEARCH, vol. 6, no. 11, novembre 1989, pages 958-960, Plenum Publishing Corp.; L. HAHN et al.: "Solid surfactant solutions of active ingredients in sugar esters" *

Also Published As

Publication number Publication date
NL195028B (nl) 2003-08-01
IT9047609A0 (it) 1990-02-08
SE9000441D0 (sv) 1990-02-07
CA2009533A1 (en) 1990-08-09
PT93079B (pt) 1996-04-30
HK37296A (en) 1996-03-15
IT1240758B (it) 1993-12-17
AU630413B2 (en) 1992-10-29
DK176209B1 (da) 2007-02-05
CH679277A5 (nl) 1992-01-31
FR2642650B1 (fr) 1994-12-09
NO301576B1 (no) 1997-11-17
NZ232401A (en) 1992-10-28
JP4073641B2 (ja) 2008-04-09
NL195028C (nl) 2003-12-02
CY1903A (en) 1996-11-22
SE9000441L (sv) 1991-08-08
DE4003844A1 (de) 1990-08-16
KR0170769B1 (ko) 1999-02-01
FI97524B (fi) 1996-09-30
MY107377A (en) 1995-11-30
PH30917A (en) 1997-12-23
CA2009533C (en) 2002-11-12
FI900604A0 (fi) 1990-02-07
JP2006001947A (ja) 2006-01-05
ATA27290A (de) 1998-05-15
AT404552B (de) 1998-12-28
LU87675A1 (fr) 1991-10-08
JP2001302538A (ja) 2001-10-31
DE4003844B4 (de) 2007-09-20
GB9002504D0 (en) 1990-04-04
KR900012625A (ko) 1990-09-01
JPH02235817A (ja) 1990-09-18
GB2230440B (en) 1993-05-19
NL9000299A (nl) 1990-09-03
NO900577L (no) 1990-08-10
AU4925290A (en) 1990-08-16
IT9047609A1 (it) 1991-08-08
GB2230440A (en) 1990-10-24
DK32790A (da) 1990-08-10
HU213394B (en) 1997-06-30
JP3484190B2 (ja) 2004-01-06
PT93079A (pt) 1990-08-31
SE511398C2 (sv) 1999-09-20
ES2021942A6 (es) 1991-11-16
NO900577D0 (no) 1990-02-07
FR2642650A1 (fr) 1990-08-10
HU900701D0 (en) 1990-04-28
DK32790D0 (da) 1990-02-07
FI97524C (fi) 1997-01-10

Similar Documents

Publication Publication Date Title
BE1003009A5 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines.
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
CA2063886A1 (en) Polyethylene protein conjugates
BE901994A (fr) Comprimes de principes actifs pharmaceutiques a delitement rapide, stables au stockage.
DK524187D0 (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
FR2696094B1 (fr) Nouvelles compositions pharmaceutiques contenant des cyclosporines.
DE69004731D1 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
MX9203026A (es) Enantiomero dextrogiro del alfa-(tetrahidro-4,5,5-tieno (3,2-c) piridil-5) (cloro-2 fenil)-acetato de metilo y composiciones farmaceuticas que lo contienen.
CA2009890A1 (en) Valproic acid
MX9402922A (es) Composiciones farmaceuticamente aceptables mejoradas.
FR2597345B1 (fr) Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
EP0369262A3 (en) Novel pyrroles
NO915116L (no) Ikke-glykosylerte human-interleukin-3-analogproteiner
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
FR2446634A1 (fr) Composition a base d'hydrolysat de lactalbumine pour le traitement et les soins de la peau
FR2362618A1 (fr) Composition de shampooing liquide a base d'ester monoalcoylique d'acide phosphorique
BE903483A (fr) Nouvelles formulations galeniques a base de bromocriptine
BE1002504A3 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
IE872239L (en) Pyridopyrimidinediones and quinazolines
TNSN97173A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et les compositions pharmaceutiques en contenant.
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
MY104813A (en) Pharmaceutical compositions of tebufelone
FR2605223B1 (fr) Compositions therapeutiques stables a base d' huile vegetale hydrophobe et son procede de preparation

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20100205